Skip to main content

Advertisement

Log in

Mucositis care in acute leukemia and non-Hodgkin lymphoma patients undergoing high-dose chemotherapy

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Purpose

This study intends to provide new insights into the incidence and care of mucositis by the epidemiological characterization of patients with hematological malignancy treated at our institution. It also aims to understand the effectiveness of several treatments used.

Methods

This is a longitudinal observational single-center study—convenience sample—which includes malignant hematologic inpatients submitted to high-dose CT from February to August 2012. We registered epidemiological data, diagnosis, oral mucositis daily questionnaire (OMDQ), World Health Organization (WHO) oral toxicity scale, and supportive medications used for mucositis.

Results

We evaluated 30 patients who had 73 episodes of hospitalization, having recorded the development of mucositis in 21.9 % (n = 16) episodes (22 patients with acute leukemia (AL) and 8 patients with non-Hodgkin lymphoma (NHL)). Grades 3–4 mucositis was reported in 4.1 % of the total episodes. The results of OMDQ showed some limitations in the quality of life, of patients with mucositis, related with the ability to eat and drink due to mouth pain (p < 0.001). In patients with NHL and AL, neutropenia entails an increased risk of mucositis (p < 0.001). Patients who did not initiate early prophylaxis with conservative measures developed mucositis earlier (p < 0.05).

Conclusions

The incidence of mucositis is high, being reported mainly in AL patients, with limitations in quality of life. Grade 4 neutropenia increases mucositis risk. Early prophylaxis with basic oral care may delay mucositis. Further studies are crucial to characterize mucositis epidemiology, physiopathology, and its management.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Peterson D, Bensadoun R, Roila F (2011) Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines. Ann Oncol 22(6):78–84

    Google Scholar 

  2. Niscola P, Romani C, Cupelli L, Scaramucci L, Tendas A, Dentamaro T, Amadori S, Fabritiis P (2007) Mucositis in patients with hematologic malignancies: an overview. Haematologica 92:222–231

    Article  PubMed  Google Scholar 

  3. World Health Organization (1979) Handbook for reporting results of cancer treatment. World Health Organization, Geneva

    Google Scholar 

  4. Stiff P (2001) Mucositis associated with stem cell transplantation: current status and innovative approaches to management. Bone Marrow Transplant 27(2):3–11

    Article  Google Scholar 

  5. Stiff P, Erder H, Bensinger W, Emmanouilides C, Gentile T, Isitt J, Lu Z, Spielberger R (2006) Reliability and validity of a patient self-administered daily questionnaire to assess impact of oral mucositis (OM) on pain and daily functioning in patients undergoing autologous hematopoietic stem cell transplantation (HSCT). Bone Marrow Transplant 37:393–401

    Article  CAS  PubMed  Google Scholar 

  6. Peterson D, Lalla R (2010) Oral mucositis: the new paradigms. Curr Opin Oncol 22:318–322

    Article  PubMed Central  PubMed  Google Scholar 

  7. Niscola P, Arcuri E, Giovannini M, Scaramucci L, Romani C, Palombi F, Trapè G, Morabito F (2004) Pain syndromes in haematological malignancies: an overview. Hematol J 5:293–303

    Article  PubMed  Google Scholar 

  8. Elting LS, Shih YC, Stiff PJ, Bensinger W, Cantor SB, Cooksley C, Spielberger R, Emmanoulides C (2007) Economic impact of palifermin on the costs of hospitalization for autologous hematopoietic stem-cell transplant: analysis of phase 3 trial results. Biol Blood Marrow Transplant 13:806–813

    Article  CAS  PubMed  Google Scholar 

  9. Elting LS, Cooksley C, Chambers M, Cantor SB, Manzullo E, Rubenstein EB (2003) The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis. Cancer 98:1531–1539

    Article  PubMed  Google Scholar 

  10. Rosenthal DI (2007) Consequences of mucositis-induced treatment breaks and dose reductions on head and neck cancer treatment outcomes. J Support Oncol 5:23–31

    CAS  PubMed  Google Scholar 

  11. Avritscher E, Cooksley C, Elting LS (2004) Scope and epidemiology of cancer therapy-induced oral and gastrointestinal mucositis. Semin Oncol Nurs 1:3–10

    Article  Google Scholar 

  12. Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M, Bekele BN, Raber-Durlacher J, Donnelly JP, Rubenstein EB (2004) Mucositis Study Section of the Multinational Association for Supportive Care in Cancer; International Society for Oral Oncology—perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology and consequences for patients. Cancer 100(9):1995–2005

    Article  PubMed  Google Scholar 

  13. National Institutes of Health/National Cancer Institute—U.S. Department of health and human services (2010) Common Terminology Criteria for Adverse Events (CTCAE). Version 4.03, 33

  14. Bulecheck G, Butcher H, Dochterman J (2010) Nursing Interventions Classification (NIC), 5th edn. Elsevier, USA

    Google Scholar 

  15. Elting LS, Cooksley CD, Chambers MS, Garden AS (2007) Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies. Int J Radiat Oncol Biol Phys 68:1110–1120

    Article  PubMed  Google Scholar 

  16. Douglas EP, Rajesh VL (2010) Oral mucositis: the new paradigms. Curr Opin Oncol 22:318–322

    Article  Google Scholar 

  17. Al-Dasooqi N, Sonis ST, Bowen JM et al (2013) Emerging evidence on the pathobiology of mucositis. Support Care Cancer 21:2075–2083

    Article  PubMed  Google Scholar 

  18. McGuire D, Fulton J, Park J, Brown CG, Correia MEP, Eilers J, Elad S, Gibson F, Oberle-Edwards LK, Bowen J, Lalla R (2013) Systematic review of basic oral care for the management of oral mucositis in cancer patients. Support Care Cancer 21:3165–3177

    Article  PubMed  Google Scholar 

  19. Keefe DM, Schubert MM, Elting LS, Sonis ST, Epstein JB, Raber-Durlacher JE, Migliorati CA, McGuire DB, Hutchins RD, Peterson DE (2007) Mucositis Study Section of the Multinational Association of Supportive Care in Cancer and the International Society for Oral Oncology. Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 109:820–831

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors acknowledge all patients and oncological hematologic staff for cooperating with this observational study.

No support or grant was used by the authors.

Conflict of interest

All authors have no conflict of interest. The authors have full control of all primary data and agree to allow the journal to review the data if requested.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sérgio Chacim.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Martinez, J.M., Pereira, D., Chacim, S. et al. Mucositis care in acute leukemia and non-Hodgkin lymphoma patients undergoing high-dose chemotherapy. Support Care Cancer 22, 2563–2569 (2014). https://doi.org/10.1007/s00520-014-2199-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-014-2199-y

Keywords

Navigation